First-Line Chemotherapy for Non–Small-Cell Lung Cancer: Is There a Superior Regimen Based on Histology?-Reference-Cited by-同舟云学术

First-Line Chemotherapy for Non–Small-Cell Lung Cancer: Is There a Superior Regimen Based on Histology?

Published:2008-07-20 Issue:21 Volume:26 Page:3485-3486
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Einhorn Lawrence H.¹

Affiliation:

1. Division of Hematology-Oncology, Indiana University Department of Medicine, Indianapolis, IN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.17.2056

Reference20 articles.

1. Pignon JP, Tribodet H, Scagliotti GU, et al: Lung adjuvant cisplatin evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol 24:366s,2006, (suppl, abstr 7008)

2. Curran WJ, Scott CB, Langer CJ, et al: Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 22:621,2003, (abstr 2499)

3. Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results

4. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

5. Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclometalated ruthenium complexes overcome cisplatin resistance through PI3K/mTOR/Nrf2 signaling pathway;Metallomics;2024-01

2. Targeted Therapies Used in the Treatment of Non–Small-Cell Lung Cancer: An Overview;Drug Repurposing for Emerging Infectious Diseases and Cancer;2023

3. Medical plants for lung cancer: an overview of current knowledge;Immunopathologia Persa;2022-12-24

4. MicroRNA-106a-5p alleviated the resistance of cisplatin in lung cancer cells by targeting Jumonji domain containing 6;Transplant Immunology;2021-12

5. Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer;Life Sciences;2021-01